Industry in brief | Probi, Karo, Venture Life, RB

19 July 2019 - Deborah Wilkes

Archived

Probi and Karo Pharma have released financial results, Venture Life is pushing on with international expansion, and RB has agreed to pay up to USD1.4 billion to settle a US investigation.

Click tags below for more information on topics:

Probi RB Karo Pharma Venture Life

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: